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Abstract
The BXD genetic reference population is a recombinant inbred panel descended from crosses between the C57BL/6 (B6)
and DBA/2 (D2) strains of mice, which segregate for about 5 million sequence variants. Recently, some of these variants
have been established with effects on general metabolic phenotypes such as glucose response and bone strength. Here we
phenotype 43 BXD strains and observe they have large variation (,5-fold) in their spontaneous activity during waking
hours. QTL analyses indicate that ,40% of this variance is attributable to a narrow locus containing the aryl hydrocarbon
receptor (Ahr), a basic helix-loop-helix transcription factor with well-established roles in development and xenobiotic
metabolism. Strains with the D2 allele of Ahr have reduced gene expression compared to those with the B6 allele, and have
significantly higher spontaneous activity. This effect was also observed in B6 mice with a congenic D2 Ahr interval, and in B6
mice with a humanized AHR allele which, like the D2 allele, is expressed much less and has less enzymatic activity than the
B6 allele. Ahr is highly conserved in invertebrates, and strikingly inhibition of its orthologs in D. melanogaster and C. elegans
(spineless and ahr-1) leads to marked increases in basal activity. In mammals, Ahr has numerous ligands, but most are either
non-selective (e.g. resveratrol) or highly toxic (e.g., 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)). Thus, we chose to examine a
major environmental influence—long term feeding with high fat diet (HFD)—to see if the effects of Ahr are dependent on
major metabolic differences. Interestingly, while HFD robustly halved movement across all strains, the QTL position and
effects of Ahr remained unchanged, indicating that the effects are independent. The highly consistent effects of Ahr on
movement indicate that changes in its constitutive activity have a role on spontaneous movement and may influence
human behavior.
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Introduction
Recent studies have highlighted the utility of the BXD murine
genetic reference population in the study of metabolism [1]. The
BXD population consists of ,100 related strains descended from
C57BL/6J (B6) and DBA/2J (D2) [2], and has wide phenotypic
variance in key traits such as blood pressure [3], body weight, and
glucose response [1] caused by ,5 million sequence variants
segregating across the population. Many specific variants have
been established as causal of overt phenotypic changes, including
SNPs in the aryl hydrocarbon receptor (Ahr) mediating TCDD
response [4], missense SNPs in alkaline phosphatase causing
impaired vitamin B6 metabolism and bone weakness [1], and a
CNV of glyoxalase 1 causing increased anxiety [5]. However, the
full phenotypic consequences of such variants in the BXDs are
only partly understood.
Ahr is a basic helix-loop-helix (bHLH) transcription factor that
has been established over the past decades as a key regulator of a
variety of processes, including embryonic development [6],
xenobiotic metabolism [7], immune response and inflammation
[8], and tumorigenesis [9]. In its inactive form, the AHR protein is
localized in the cytoplasm with a variety of chaperones, such as
HSP90. When activated, AHR dissociates from its chaperones,
dimerizes with the aryl hydrocarbon nuclear translocator (ARNT)
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[10], and translocates to the nucleus. This complex then induces
the transcription of a multitude of target genes [11]. In vertebrates,
AHR is constitutively active but can also be activated by
endogenous ligands such as kynurenine and dietary compounds
such as indirubin [8,12]. These ligands can induce diverse
transcriptional networks leading to distinct phenotypic outcomes.
For example, indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) are both high-affinity AHR ligands [13], yet the former is
a anti-cancer compound, while the latter is a potent toxin [14,15].
Natural variants in Ahr are also known to strongly affect the
activity of AHR within and across species [16,17], such as in mice,
where C57BL/6J (B6) and DBA/2J (D2), the parents of the BXDs,
have a ,20-fold difference in AHR activity due to several
missense SNPs [18].
Through the systematic measurement of a large population of
BXD mice, we observed large variations in spontaneous activity, a
large portion of which was attributable to a single genetic locus on
chromosome 12. With the aid of genomic and transcriptomic data,
we inferred Ahr as the most likely candidate gene responsible for
this effect. Through a cross-species approach, from humanized
AHR mice, to heterozygotic Drosophila melanogaster mutants and
Caenorhabditis elegans exposed to RNAi, we were able to
conclude both that Ahr is the quantitative trait gene (QTG) and
that in each case, reducing its expression increases movement.
Subsequently, we examined the effects of high fat diet (HFD) in the
BXDs and establish that, while it robustly decreases movement
and increases weight, the effects of Ahr remain strong and entirely
independent. Together, these data indicate a striking new
moonlighting phenotypic role for Ahr in the control of locomotor
activity.
Results
Identification of a QTL Influencing Movement
We established a colony of 43 BXD strains and designed a basic
phenotyping program to examine how two basic metabolic
parameters—activity and weight—vary, and how much of this
may be attributed to genetic variants in the population. In a
previous study, we examined how many metabolic traits vary due
to sex in the BXDs [1], but did not examine basal movement. We
thus examined 68 female and 68 male retired breeders from 22
BXDs strains at approximately 20 weeks of age. Animals were
placed individually in normal housing cages and spontaneous
movement recording over a 48 hour period. Females were slightly
more active (Figure 1A), and movement was highly variable for
both sexes (,3-fold for ambulations and ,4-fold for rearing), but
overall, movement was strongly correlated by strain between males
and females (Figure 1B), with the range of across genotypes (,5-
fold range) dramatically outweighing the range across the sexes
(,1.3-fold).
To search for the genetic drivers of movement, we designed an
enlarged phenotyping program to examine activity in male BXDs
using a larger population sample: 43 strains with 5 animals per
cohort phenotyped at precisely 23 weeks of age, using the same
diet and recording setup. In the expanded data, both rearing and
ambulatory activity again varied dramatically across the popula-
tion—5-fold and 8-fold respectively (Figure 1C). The two aspects
of movement were tightly correlated by strain (Figure 1D) and
highly consistent for all five biological replicates within each strain,
yielding high estimates of heritability (h2 = 0.59 for ambulations,
and h2= 0.68 for rearing, shown in Figure 1E). The BXD
population likewise had highly variable body weights across the
population (,2-fold range) with a high estimate of heritability
(h2 = 0.74). Surprisingly however, spontaneous activity had no
association with body weight or food intake (Figure 1F), indicating
the strains’ movement is driven primarily by internal motivating
factors, rather than by access to food or water, both of which
require rearing to reach. Due to the strong heritability and wide
and consistent cross-strain variance, we suspected that the
movement variation may be linked to quantitative trait loci
(QTLs), which could indicate the region(s) of the genome causing
the genotypically-driven effects. For both measurements, rearing
and ambulation, we detected overlapping QTLs, with the narrow-
sense peak located on chromosome 12 from 35.5 to 37.6 Mb, and
the broad-sense peak QTL from 30.3 to 37.6 Mb (Figure 1G). For
ambulatory activity, this locus explains 25% of the overall
variance, or 1300 counts/hr, and for rearing the same locus
explains 41% of the variance, or 400 counts/hr (Figure 1H).
While the movement parameters mapped to several suggestive
and two significant loci, the significant locus on chromosome 12
was the most striking and consistent (Figure 2A), thus we
prioritized it for validation. To establish the effect of the Chr12
locus, we examined a congenic strain of B6 with the D2 locus at
the region of interest (B6.D2N-Ahrd) [16]. We sequenced this line
and observed it carries a 6 Mb segment of D2 genome on Chr 12
between 34.60 and 40.48 Mb, while the rest of the genome is B6
(though several dozen individual SNPs—i.e. spontaneous muta-
tions—are observed elsewhere in the genome, see Materials &
Methods). Ten males from all three cohorts were then entered into
the same phenotyping platform until 23 weeks of age, at which
point the movement experiment was performed. As predicted, the
congenic line and D2 moved significantly more than the B6
animals, while the congenic line and D2 moved the same amount
(Figure 2B), validating the QTL as causative of movement
variance. Moreover, these increases matched the calculated effect
size from the QTL: ambulatory activity increased by 1500 counts/
hr, while rearing activity increased by 380 counts/hr. This analysis
validated the QTL as influencing movement, though did not
indicate which candidate gene(s) cause the effect (Figure 2C). The
broad-sense QTL, from 30.3 to 37.6 Mb, contains 38 genes,
including 9 which are under the narrow-sense QTL (35.5 to
37.6 Mb). The congenic region, from 34.6–40.5 Mb, contains 17
Author Summary
Using 43 strains from the BXD mouse reference popula-
tion, we observed a 5-fold difference in spontaneous
activity. QTL analysis indicated that ,40% of this variance
is due to the aryl hydrocarbon receptor (Ahr). Ahr is a
conserved transcription factor found in nearly all multicel-
lular organisms and implicated in a multitude of functions,
ranging across development, liver metabolism, and neu-
ronal health. This gene is highly variant in the BXDs, and
strains with the low-active Ahr allele have significantly
higher voluntary locomotion. This increase is also observed
in independent mouse models, which have reduced Ahr
activity, including in transgenic mice with humanized AHR.
Furthermore, decreasing Ahr expression in C. elegans and
Drosophila causes similar, robust increases in spontaneous
movement. This link is independent of major environmen-
tal perturbations as well: BXD strains fed high fat diet long-
term move only half as much as their chow-fed brethren,
yet the effects of Ahr were consistent and equally strong in
both dietary cohorts. While Ahr is a highly liganded
transcription factor in mammals, these data indicate that
modifications to its constitutive activity are sufficient to
control movement. However, certain ligands may be able
to specifically act on this phenotypic aspect of the gene.
Ahr - A Conserved Regulator of Movement
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genes, 13 of which are within the QTL bounds. We retained all 42
genes (38 within the QTL, 4 exclusively in the congenic region) for
subsequent bioinformatic analyses, though with a particular eye
for the 9 genes overlapping in the congenic and significant narrow-
sense QTL.
Selecting the QTG
To select candidate genes for validation experiments, we used
several established methods to prioritize candidate gene(s), which
are most likely to influence movement [19]. First, the sequence
variants were examined for all candidate genes, including within
5 kb of the 39 or 59 untranslated regions. 10 of the candidates are
identical by descent across all of the BXD strains, making these
genes unlikely to be causal for the QTL [20], including 3 of the 9
priority candidates. For the 32 genes with sequence variants, seven
have protein-coding changes: peroxidasin homolog (Pxdn), thyroid
peroxidase (Tpo), histone deacetylase 9 (Hdac9), mesenchyme
homeobox 2 (Meox2), transmembrane proteins 18 and 195
(Tmem18 and Tmem195), and Ahr. To further rank the candidate
genes, we examined the transcriptional variance and regulation in
Figure 1. Identification and validation of a movement QTL. (A) Nighttime rearing and ambulatory activity for all 68 males and 68 females
phenotyped across 22 (male) and 19 (female) strains. These 19 strains were phenotyped in both sexes. Females are slightly more active. (B) Despite
moving somewhat more, female and male activity are strongly correlated by strain. (C) Nighttime rearing and ambulatory activities for all 196 animals
across 43 strains. Each strain has ,5 biological replicates. (D) Ambulatory and rearing activity are tightly correlated, though the measurements are
technically independent. (E) Nighttime rearing activity for all 43 strains, ordered by value. Activity varies by 3.9 fold across the population. The strong
heritability (h2) of 0.68 indicates that the majority of this variance can be attributed to genetic factors. (F) Body weight (Left) and food intake (Right)
have no effect on ambulatory or rearing activity, suggesting movement is largely independent of the weight or the need to eat or drink. Animals
must rear to reach the food basket or drink. (G) Rearing and ambulatory movement mapped to a common narrow 2 Mb locus on chromosome 12.
(H) The target locus (chromosome 12 from 35.5–37.6 Mb) explains ,40% of variance (r2) in rearing activity and ,25% of variance in ambulatory
activity.
doi:10.1371/journal.pgen.1004673.g001
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Figure 2. Identification of the movement QTG: Ahr. (A) The movement QTLs across all chromosomes indicates one consistently significant
locus on chromosome 12, and one significant locus on chromosome 19 only for rearing activity. (B) A congenic strain on a B6 background with a D2
congenic interval at the region of the chromosome 12 QTL has significantly more spontaneous movement, validating that this locus impacts
movement. One-way ANOVA is suggestive (p= 0.09), while the t-test between only the congenic and control groups is significant (p= 0.01). (C) Close-
up of the congenic (red) and overlapping significant QTL (black) and suggestive (yellow) regions on chromosome 12. All genes are represented by
rectangles at their approximate chromosomal positions. Genes that are sequence identical across the BXDs are marked in grey and were discounted.
Genes with sequence variants of unknown effect (maroon) and genes with sequence variants with clear effects (e.g. coding differences, red) were
considered more likely candidate QTGs. (D) eQTLs were plotted for all positional candidates in all eight datasets tissues. Five genes map to
chromosome 12 (,25–45 Mb) as cis-eQTLs. As the movement QTL also maps to this locus, trans-eQTLs are of less interest. (E) Transcript variance was
checked across all 9 datasets. Half of the transcripts are at least moderately variable (range .1.75 fold) across the cohorts, while 9% of transcripts are
highly variable (.3.0 fold). Upper stripchart: Variance of all 42 candidate genes in all 8 tissues (i.e. each gene is represented ,8 times). Lower
stripchart: Variance of all 42 candidate genes in CD liver. (F) Few transcripts are consistently expressed across strains in different tissues (Brown
Adipose: B; Liver: L; Muscle: M; Hypothalamus: H, Pituitary: P, Adrenal: A; F: High fat fed cohorts; all others are chow fed). Ahr covaries well for all five
datasets taken from this study, but negatively with the three publicly available BXD datasets; Acp1 covaries positively in all datasets, although much
stronger in the five paired sets. Most other genes (e.g. the four shown) have little consistency. (G) Gene expression correlates with movement
inconsistently by tissue, with only a handful of genes yielding consistent (Acp1, Tpo, Tmem18) or significant (Ahr, Acp1) correlations. Nominally
significant correlations (p,0.05) are displayed on the chart. For brown adipose tissue, no genes correlate highly significantly (p,0.01) with activity.
doi:10.1371/journal.pgen.1004673.g002
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eight diverse microarray datasets. Candidate genes with higher
transcript variability, which have strong genetic variants at the
same locus as the phenotype, and/or which associate with the
phenotype are more likely to be the QTG under the QTL [19].
First, we examined the 42 genes in 8 datasets from 6 tissues. In
three tissues—liver, brown adipose (BAT), and quadriceps—
measurements were performed in the same BXD animals, which
mapped to the movement QTL. Quadriceps and liver were also
sampled in the same BXD strains on a high fat diet. The other
three tissues—hypothalamus, pituitary, and adrenal—were col-
lected previously and published by other research groups in the
same BXD strains in similar conditions (i.e. age, sex, diet) [21]. All
transcripts were detected in at least one tissue except Slc26a3 (in
the congenic interval) and Prps1l1 (in the narrow QTL region).
We then mapped all transcripts to identify the existence and
location of significant expression QTLs (eQTLs; LRS$20,
Figure 2D). No trans-eQTLs were consistent across more than
one dataset, while four genes gave consistent significant cis-
eQTLs: acid phosphatase 1 (Acp1, in 5 datasets), Tmem18 (in 4),
Ahr (in 3) and syntrophin gamma 2 (Sntg2, in 3). We then
examined the transcript variance of all candidate genes in the eight
datasets. Most genes had at significant variability across the strains
in each tissue (50% have variance $1.75 fold; Figure 2E), with
three genes, Sh3yl1, Prkar2b and Acp1, being particularly highly
variable (range$3.0 fold) in multiple tissues. However, most genes
did not covary across the tissues, with only two having particularly
consistent expression: Ahr and Acp1 (Figure 2F). We last
examined how the expression of each gene associated with
movement phenotypes in the BXDs, with particular focus on
candidates under the significant QTL and congenic locus (e.g.
Ahr, Sostdc1, Ispd) and those with major or consistent transcript
variance (e.g. Acp1, Prkar2b, and again Ahr). Only two genes, Ahr
and Acp1 had significant correlations after multiple testing
correction (Figure 2G), though several other genes yielded
consistent but non-significant correlations (e.g. Tmem18). Togeth-
er, these bioinformatic analyses indicated several genes as
potentially causative of movement variance, and with one top
candidate: Ahr, which was prioritized as the first gene for
validation as the quantitative trait gene (QTG), as the other
strong candidate gene, Acp1, was not in the congenic region or
under the peak QTL.
The Effect of Ahr on Movement Is Highly Conserved
Across Evolution
Ahr is strongly conserved throughout evolution (Figure 3A), and
acts as a bHLH-type transcription factor with impact on
development and homeostasis in all species [22]. Given this
consistency, we examined whether movement regulation may be
another conserved physiological process regulated by the gene. In
the BXDs, three particular SNPs have been established as causal
for differences in Ahr by affecting its enzymatic activity (A375V),
ligand binding and the cis-regulatory mechanism (L471P), and
protein length (*805R, which adds 43 amino acids to the C
terminus) [18,23]. Strikingly, these three particular variants are
conserved in humans, with the most common human allele
(hAHR) humans matching the D2 allele at all three (Figure 3B)
[24]. Correspondingly, hAHR enzymatic activity is similar to that
of D2 mice [24,25]. Moreover, the valine at position 375 (or 381 in
humans) is unique among mammalian reference genomes to D2
and humans, and is not even found in macaques, which likewise
have much higher Ahr activity than humans and D2-type mice
[26,27]. To examine a potential link between hAHR and activity,
we phenotyped transgenic B6 mice with the hAHR allele replacing
the murine Ahr [28]. In the same home cage monitoring
experiments as those used before, we observed that the humanized
animals were significantly more active than their wildtype
counterparts (Figure 3C), and again with an increase equal to
that of the congenic line (Figure 2A). This finding indicates both
that Ahr was properly selected as the QTG, and that the effect
may well be conserved cross species. To validate this hypothesis,
we looked to lower organisms.
The key transcription factor motifs in Ahr (bHLH and PAS) are
highly conserved in the D. melanogaster ortholog called spineless
(ss) [29], and the C. elegans homolog called ahr-1 [30], thus we
hypothesized the regulation of movement may be further
conserved to these simpler model organisms. We first examined
movement in D. melanogaster, where we crossed the w strain with
a loss of function allele ssD115.7 [29], and examined this line as a
heterozygous knockout, both in males and females. In both
models, ss reduction resulted in a robust ,25% increase in
movement (Figure 3D). Given the conservation to D. melanoga-
ster, we hypothesized that this connection may manifest also in C.
elegans. As before, inhibition of ahr-1 by RNAi resulted in a
marked and robust increase in activity (Figure 3E). Moreover, the
data in C. elegans indicates that the effect of Ahr inhibition on
activity is approximately linear, at least within the expression
variation tested. Full knockouts in mice, while viable, have poor
postnatal survival rates [31] and have dramatically smaller livers
(,50% size [32]); likewise, full knockouts in Drosophila of ss have
notable morphological problems [22].
Ahr inhibition robustly increased movement in all models
examined, and the effect was observed in the absence of any
clearly established Ahr ligand. In Drosophila and C. elegans, the
Ahr orthologs are suspected to be exclusively constitutively active
[33]. However, this does not indicate whether it is constitutive
activity operating in the mice, or if it is an unknown dietary
component of the chow diet common to all cohorts, which could
influence movement in a ligand-dependent manner. As known Ahr
ligands are either known to be non-selective and activate multiple
signaling pathways (e.g. resveratrol or quercetin [34,35]) or are
highly toxic and poorly suited for normal physiological studies (i.e.
TCDD), we chose to expose BXD cohorts to an environmental
component that is known to influence movement: a high fat diet
(HFD). We raised males from the same BXD strains, but now on a
HFD from 8 until 23 weeks of age at which point we again
measured spontaneous activity (Figure 4A). HFD robustly increas-
es body weight by this age, by about 12 grams or ,35% of body
weight in each strain (Figure 4A). Movement is similarly affected,
with rearing decreasing by ,50% (Figure 4B) and ambulatory
movement by ,25%. Strikingly, both movement parameters
again map to the same locus on Chromosome 12, indicating the
genetic effect of this locus is independent of the dietary influence
on movement (Figure 4C). Moreover, the dietary effect is
consistent across all strains (Figure 4D, left) and is not directly
due to the increase in body weight (Figure 4D, right). Thus, while
there may be a gene-by-environment effect of diet on movement in
the BXDs, it is independent of Ahr, which is equally expressed in
both dietary cohorts. As in the CD cohorts, Ahr expression has a
strong negative correlation with spontaneous activity in the HFD
population (Figure 4E). This independent phenotype both con-
firms the locus identified using CD cohorts, but also indicates that
Ahr can influence movement in mammals independently of
incidental dietary or environmental effects.
Discussion
In this study we characterized 43 strains in the BXDs genetic
reference population to assess basal physiological parameters:
Ahr - A Conserved Regulator of Movement
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movement and body weight. Both phenotypes are driven by
numerous and complex interactions between genes and environ-
ment, and also by neurological/motivational states and by
physiological limitations. In the BXDs, body weight and activity
are sexually dimorphic, highly variable, and heritable. Surprising-
ly, body weight and food intake have no impact on standard
spontaneous activity in either CD or HFD-fed cohorts despite a
major decrease in movement in HFD cohorts. In both dietary
groups, we identified a single common QTL causal of ,25–40%
of the variance of movement across the population. Using a
congenic line, we confirmed the effect of this locus and set out to
establish the causal gene through a bioinformatics approach. By
analyzing nine diverse tissues, five in the cohorts phenotyped and
three from other published BXD studies, we were able to establish
the aryl hydrocarbon receptor (Ahr) as the single best candidate
gene for mechanistic validation.
Ahr is an evolutionary conserved transcription factor involved in
development, signal transduction, and metabolism [36,37]. Ahr
has constitutive activity, but can also be activated by a variety of
ligands such as the endogenous metabolite, kynurenine, and a
Figure 3. Evolutionary analysis links Ahr to movement. (A) Phylogenetic BLAST analysis of mouse Ahr showed that the gene is highly
conserved down to simple multicellular animals such as C. elegans, the gene likely has conserved basic metabolic functions. (B) Sequence analysis of
the three missense mutations of Ahr between B6 and D2 known to have an impact oh AHR activity (375, 471, 805). (C) B6 mice with the humanized
AHR allele are nearly twice as active as controls. The humanized AHR allele is similar to the D2 allele in many tests of enzymatic activity, with a,90%+
reduction in activity compared to the B6 allele [24]. (D) D. melanogaster with a heterozygous deletion allele of the Ahr ortholog ss are also
significantly more active than controls. The 50% reduced expression appears to increase movement by about 20% in both males and females. Each
comparison is a separate Welch’s t-test with p,0.001. Females are ,30% less active than males in both instances (p,0.001). (E) C. elegans treated
from early development with RNAi for ahr-1 are nearly twice as active as worms treated with a control vector. Reduced doses of RNAi have
intermediary effects on activity. p=2.9e-6 for 100% vs. empty vector (ev).
doi:10.1371/journal.pgen.1004673.g003
Ahr - A Conserved Regulator of Movement
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wide variety of environmental chemicals. Moderate to strong
(,95%) reductions in Ahr activity appear to have little negative
effect an organism’s health or viability, whether in D2 or
humanized hAHR mice, or in heterozygotic fly mutants. Through
cross-species analysis to Drosophila and C. elegans, we were able to
confirm that reducing the expression of this gene consistently leads
to an evolutionarily consistent increase in spontaneous movement.
After examining the same BXD strains on a HFD, we observed
that despite a major decrease in movement in this population, the
Ahr QTL is consistent and with a similar effect size, independently
of this major environmental perturbation. This conserved effect in
BXDs across different environmental conditions indicates a
constitutive role for Ahr in the regulation of movement in
vertebrates as well. The observation that reduction of Ahr
orthologs in invertebrates has a consistent effect on movement
furthers this hypothesis, as the Drosophila ortholog (spineless) is
constitutively active [38] and does not appear to be affected by any
exogenous ligands [33]. A large number of AHR polymorphisms
have been identified in large and diverse human population studies
[39,40], though it remains to be seen if these variants lead to
variation in locomotion and/or disposition to exercise in humans
as in mice. However, as the movement link is conserved in mice
with a humanized Ahr allele, it seems likely that natural variation
in Ahr or of its ligands may explain part of the natural variation in
human proclivity for activity. Furthermore, while our data indicate
constitutive Ahr activation as a regulator of movement, it is
conceivable that this role may be further modulated by specific
ligands in mice and humans. In combination, our study expands
the phenotypic roles of AHR, endowing it with a commanding
role in the control of movement that is conserved across evolution.
Methods
Animals
All animals were communally housed by strain until phenotyp-
ing and fed a chow diet (CD; (Harlan 2018; 6% kCal/fat, 20%
kCal/protein, 74% kCal/carbohydrate) throughout life after
weaning. All BXD strains (BXD43–103) were originally sourced
from the vivarium at the University of Tennessee Health Science
Center (Memphis, TN, USA) then bred for two or more
generations until progeny entered the phenotyping colony.
Male versus Female Phenotyping: 136 retired breeders (68
female, 68 male) from 22 strains (male) or 19 strains (female; all 19
overlap) were taken at 2064 weeks of age from a breeding colony
at the EPFL facility and transferred to the phenotyping unit. Males
and females were separated for 3+ weeks to ensure pregnant
females were not phenotyped. Males and females were pheno-
typed on separate days, with 10–16 animals entered into the
phenotyping program every 2 days.
CD Male Phenotyping: 196 male mice from 43 strains of the
BXD family were bred at the EPFL facility and transferred to the
phenotyping unit at 8 weeks of age. Each cohort was communally
housed (3–5 animals per cage) under 12 h light, 12 h dark cycle
with ad libitum access to food and water at all times. Animals were
in solitary cages only for the movement phenotyping test
(48 hours) and were sacrificed 5 weeks after at ,28 weeks of age.
Figure 4. Environmental effects on movement and Ahr. (A) Weight is significantly increased in cohorts fed HFD (dark blue) by 23 weeks of
age—after 15 weeks on HFD—compared to the CD-fed cohorts (light blue). (B) Rearing activity and ambulatory activity are significantly reduced by
HFD feeding. (C) Both movement parameters also map significantly to the Ahr locus in BXDs fed HFD, indicating that the effect of HFD on movement
is independent of this locus. (D) Left: Rearing and movement activity in HFD cohorts correlates well with the movement of chow diet (CD) cohorts run
previously. Right: Body weight has no effect on spontaneous activity in mice on HFD, which is similar as observed previously for animals on CD. (E)
Ambulatory activity (left) and rearing activity (right) correlations with Ahr expression in CD and HFD BXD cohorts. Ahr expression is unaffected by
HFD.
doi:10.1371/journal.pgen.1004673.g004
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HFD Male Phenotyping: 186 animals from 42 strains (all but 1
overlapping) were entered into the colony as before, with HFD
starting at 8 weeks of age (Harlan 06414; 60% kCal/fat, 20%
kCal/protein, 20% kCal/carbohydrate). Animals were in solitary
cages only for the movement phenotyping test (48 hours) and were
sacrificed 5 weeks after at ,28 weeks of age.
Congenic AHR mice were purchased from The Jackson
Laboratory (stock number 002921), with animals delivered at 8
weeks of age along with control B6 and control D2 mice. The
congenic mice were generated by crossing B6 with D2, followed by
successive backcrossing (N13) to return the B6 genome except in
the region of Ahr [16]. The congenic region was genotyped
independently to confirm the size of the interval. We then
sequenced the DNA of the congenic strain using an Ion Proton PI
Chip at 1.56depth (i.e. ,15 million 200 bp reads) and aligned it
against the C57BL/6J reference. We confirmed the reported
congenic interval is the only region that retains a D2 background.
Several dozen SNPs were observed throughout the genome
outside the reported Chr12 interval (,34.6 to 40.5), but were
distributed evenly across the chromosomes and consequently
represent spontaneous mutations or sequencing and assembly
errors, rather than residual D2 genotype. 10 humanized AHR
mice were ordered from Taconic (model 9165), delivered at 8
weeks of age along with B6 controls [25]. The transgenic mice
have exons 3–11 (of 11) replaced with hAHR, while exons 1–2
retain the B6 sequence, retaining 2 amino acids unique to B6 not
present in hAHR. The key mutations (375, 471, and the lost stop
codon) are present in the transgenic animal.
For tissue collection on CD and HFD BXD cohorts, animals
were sacrificed under isoflurane anesthesia and cardiac perfusion
after an overnight fast. High fat diet treatment and two day
isolation for the recording experiment were considered as having
low impact on the animals’ welfare, while all other measurements
and conditions were considered as having no negative impact. All
research was approved by the Swiss cantonal veterinary authorities
of Vaud under licenses 2257.0 and 2257.1.
Movement Phenotyping Tests
Home cage monitoring was performed at 2361 weeks of age for
all mice except retired breeders (2364 weeks), using a laser
detection grid developed by TSE Systems (Bad Homburg,
Germany) and used in the animals’ standard housing cages. The
detection grid has two layers: one for detecting X-Y movement
(‘‘ambulations’’) the other for Z movement (‘‘rearings’’). Both
measurements are technically independent, though the measure-
ments of movement are strongly correlated (r,0.70, see
Figure 1B). Animals were housed individually for the 48-hour
experiment starting at about 10am, with the night cycles (7pm–
7am with 30 minutes of both dawn and dusk) used for movement
calculations [41].
D. melanogaster lines containing a null mutation in the spineless
gene, the D. melanogaster ortholog of Ahr, w; ssD115.7/TM3, were
obtained courtesy of Ian Duncan’s laboratory and passaged for
two generations in a standard incubator. This line was crossed
with w2 and the progeny segregated accordingly (i.e. w vs.
w;ssD115.7 and w;TM3, hb-LacZ vs. wssD115.7/TM3, hb-LacZ).
Movement was recorded by placing flies in a sealed chamber,
tapping the chamber, and recording their movement as they
naturally climb towards the top. For the tapping test, 1–2 day old
flies were recorded using a standard SLR camera with a Leica
macro objective. The experiment was performed four times for
each cohort with one minute recordings each, with a ‘‘tap’’
sending the flies to the bottom of the chamber every 10 seconds.
The speed with which flies reached the top of the chamber was
measured using the Parallel Worm Tracker for MATLAB, which
we modified slightly to work with D. melanogaster [42]. This speed
was converted into distance by taking the area-under-the-curve
(AUC) integral of their velocity.
C. elegans movement was recorded for 45 seconds at days 2, 3,
and 4 of adulthood using a Nikon DS-L2/DS-Fi1 camera and
controller setup, attached to a computerized Nikon bright field
microscope. Seven plates of worms, with 10 worms per plate, were
measured in each condition. The movement of worms during this
time was calculated by following the worm centroids using the
same modified version of the freely-available for the Parallel
Worm Tracker as above.
Bioinformatics and Statistical Analysis
R was used for basic analysis of phenotypic data. GeneNetwork
(www.genenetwork.org) was used for correlation and genetic
analyses. The original phenotypes published in this paper and all
microarray data generated in these cohorts are available for public
analysis or download using the GeneNetwork database (Species:
Mouse, Group: BXD, Type: Adipose mRNA, Liver mRNA, or
Muscle mRNA, then select the EPFL datasets). The three
historical BXD mRNA datasets, for adrenals, pituitary, and
hypothalamus, are also available here [43].
Phenotype data were checked for normality using the Shapiro-
Wilk test, with a W-value $0.80 accepted as approximately
normal. Heritability was calculated by one-way ANOVA—the
aov() function in R—taking the sum of squares of within-strain
variance divided by the total sum of squares variance. Dot plots
are represented as individual measurements, or mean+SEM
depending on the figure panel. Dot plots with error bars (e.g.
Figure 1D) indicate each dot is a strain average of ,5 individuals.
Individual QTL plots consider a suggestive LRS$12 and
significant LRS$18. Large scale QTL plots (Figure 2D) use
LRS$20 for significance due to multiple testing. Welch’s t-tests
were performed for two-way comparisons between phenotype
data, as variances were typically unequal in these comparison
groups. Student’s t-tests were performed for array data, as all data
are normally distributed with equal variance. Pearson’s r is
calculated for correlation plots as no outliers were observed. A p-
value of less than 0.05 was considered the significance threshold
for all analyses, except in QTL mapping when correction for
multiple testing was used. All BXD phenotype data can be found
on GeneNetwork.org under the ‘‘Type: Phenotype’’ entry then by
searching for ‘‘Lisp3’’.
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